Omeros Corp. (OMER) Obtains Licenses from Asubio Pharma for Compunds to be Used in PDE7 Program
Tweet Send to a Friend
Omeros Corporation (NASDAQ: OMER) today announced that it has obtained an exclusive license to compounds from Asubio Pharma Co., Ltd ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
